Effectiveness and implications of alternative placebo treatments: A systematic review and network meta-analysis of osteoarthritis trials

Annals of Internal Medicine

Volumn 163, Issue 5, 2015, Pages 365-392

  Bannuru, Raveendhara R ^a   McAlindon, Timothy E ^a   Sullivan, Matthew C ^a   Wong, John B ^a   Kent, David M ^a   Schmid, Christopher H ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; CORTICOSTEROID; CYCLOOXYGENASE 2; HYALURONIC ACID;

ANALGESIA; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFICACY; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; META ANALYSIS; OUTCOME ASSESSMENT; PLACEBO EFFECT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TOPICAL TREATMENT; OSTEOARTHRITIS, KNEE; PAIN; STANDARDS;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; HUMANS; HYALURONIC ACID; OSTEOARTHRITIS, KNEE; PAIN; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84940550771     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-0623     Document Type: Article

References (178)

1. Bijlsma JW, Welsing PM. The art of medicine in treating osteoarthritis: I will please [Editorial]. Ann Rheum Dis. 2008;67:1653-5. [PMID: 19005153] doi:10.1136/ard.2008.097006
2. Koshi EB, Short CA. Placebo theory and its implications for research and clinical practice: a review of the recent literature. Pain Pract. 2007;7:4-20. [PMID: 17305673]
3. Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001;344:1594-602. [PMID: 11372012]
4. Wampold BE, Minami T, Tierney SC, Baskin TW, Bhati KS. The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials. J Clin Psychol. 2005;61: 835-54. [PMID: 15827993]
5. Hahn RA. The nocebo phenomenon: concept, evidence, and implications for public health. Prev Med. 1997;26:607-11. [PMID: 9327466]
6. Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet. 2011;378: 1306-15. [PMID: 21851976] doi:10.1016/S0140-6736(11)60873-8
7. Naudet F, Millet B, Charlier P, Reymann JM, Maria AS, Falissard B. Which placebo to cure depression? A thought-provoking network meta-analysis. BMC Med. 2013;11:230. [PMID: 24160565] doi:10.1186/1741-7015-11-230
8. Meissner K, Fässler M, Rücker G, Kleijnen J, Hróbjartsson A, Schneider A, et al. Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA Intern Med. 2013; 173:1941-51. [PMID: 24126676] doi:10.1001/jamainternmed.2013.10391
9. Bannuru RR, Schmid CH, Kent DM, Vaysbrot EE, Wong JB, McAlindon TE. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis. Ann Intern Med. 2015;162:46-54. [PMID: 25560713] doi:10.7326/M14-1231
10. Manyanga T, Froese M, Zarychanski R, Abou-Setta A, Friesen C, Tennenhouse M, et al. Pain management with acupuncture in osteoarthritis: a systematic review and meta-analysis. BMC Complement Altern Med. 2014;14:312. [PMID: 25151529] doi:10.1186/1472 -6882-14-312
11. Higgins JPT, Altman DG, Sterne JA. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration; 2011.
12. Juhl C, Lund H, Roos EM, Zhang W, Christensen R. A hierarchy of patient-reported outcomes for meta-analysis of knee osteoarthritis trials: empirical evidence from a survey of high impact journals. Arthritis. 2012;2012:136245. [PMID: 22792458] doi:10.1155/2012/136245
13. Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis-meta-analysis. Osteoarthritis Cartilage. 2011;19:611-9. [PMID: 21443958] doi:10.1016/j.joca.2010.09.014
14. Cooper H, Hedges LV. The Hand Book of Research Synthesis. New York: Russell Sage Foundation Publications; 1994.
15. Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3:80-97. [PMID: 26062083] doi:10.1002/jrsm.1037
16. Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making. 2013;33:607-17. [PMID: 23104435] doi:10.1177/0272989X12458724
17. Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29: 932-44. [PMID: 20213715] doi:10.1002/sim.3767
18. Thorlund K, Walter SD, Johnston BC, Furukawa TA, Guyatt GH. Pooling health-related quality of life outcomes in meta-analysis-a tutorial and review of methods for enhancing interpretability. Res Synth Methods. 2011;2:188-203. [PMID: 26061786] doi:10.1002/jrsm.46
19. Pham T, van der Heijde D, Altman RD, Anderson JJ, Bellamy N, Hochberg M, et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage. 2004;12:389-99. [PMID: 15094138]
20. Dias S, Sutton AJ, Welton NJ, Ades AE. Evidence synthesis for decision making 3: heterogeneity-subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making. 2013;33:618-40. [PMID: 23804507] doi:10.1177/0272989X13485157
21. Conaghan PG, Dickson J, Bolten W, Cevc G, Rother M. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology (Oxford). 2013;52:1303-12. [PMID: 23542612] doi:10.1093/rheumatology/ket133
22. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2008;67:1716-23. [PMID: 18541604] doi:10.1136/ard.2008.092015
23. Morison RA, Woodmansey A, Young AJ. Placebo responses in an arthritis trial. Ann Rheum Dis. 1961;20:179-85. [PMID: 13772684]
24. Traut EF, Passarelli EW. Placebos in the treatment of rheumatoid arthritis and other rheumatic conditions. Ann Rheum Dis. 1957;16: 18-22. [PMID: 13412002]
25. Kaptchuk TJ, Stason WB, Davis RB, Legedza AR, Schnyer RN, Kerr CE, et al. Sham device v inert pill: randomised controlled trial of two placebo treatments. BMJ. 2006;332:391-7. [PMID: 16452103]
26. Grenfell RF, Briggs AH, Holland WC. A double-blind study of the treatment of hypertension. JAMA. 1961;176:124-8. [PMID: 13708477]
27. National Clinical Guideline Centre. Osteoarthritis. Care and management in adults. London, United Kingdom: National Institute for Health and Care Excellence; 2014.
28. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al; American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64:465-74. [PMID: 22563589]
29. McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014; 22:363-88. [PMID: 24462672] doi:10.1016/j.joca.2014.01.003
30. Jonas WB. Reframing placebo in research and practice. Philos Trans R Soc Lond B Biol Sci. 2011;366:1896-904. [PMID: 21576147] doi:10.1098/rstb.2010.0405
31. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet. 2010;375:686-95. [PMID: 20171404] doi:10.1016/S0140-6736(09)61706-2
32. Thomas KB. General practice consultations: is there any point in being positive? Br Med J (Clin Res Ed). 1987;294:1200-2. [PMID: 3109581]
33. Miller FG, Rosenstein DL. The nature and power of the placebo effect. J Clin Epidemiol. 2006;59:331-5. [PMID: 16549251]
34. Case JP, Baliunas AJ, Block JA. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. Arch Intern Med. 2003;163:169-78. [PMID: 12546607]
35. Miceli-Richard C, Le Bars M, Schmidely N, Dougados M. Paracetamol in osteoarthritis of the knee. Ann Rheum Dis. 2004;63:923-30. [PMID: 15249319]
36. Pincus T, Koch G, Lei H, Mangal B, Sokka T, Moskowitz R, et al. Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Ann Rheum Dis. 2004;63:931-9. [PMID: 15082468]
37. Altman RD, Zinsenheim JR, Temple AR, Schweinle JE. Threemonth efficacy and safety of acetaminophen extended-release for osteoarthritis pain of the hip or knee: a randomized, double-blind, placebo-controlled study. Osteoarthritis Cartilage. 2007;15:454-61. [PMID: 17142063]
38. Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M, Blanco FJ, Benito P, Martín-Mola E, et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007;56:555-67. [PMID: 17265490]
39. Yocum D, Fleischmann R, Dalgin P, Caldwell J, Hall D, Roszko P. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators. Arch Intern Med. 2000;160: 2947-54. [PMID: 11041902]
40. Ghosh S, Paul S, Das N, Bhattacharyya TK. A study on the effects of diclofenac sodium and etoricoxib in the treatment of osteoarthritis. J Indian Med Assoc. 2007;105:260-2. [PMID: 17915794]
41. Davies GM, Watson DJ, Bellamy N. Comparison of the responsiveness and relative effect size of the western Ontario and McMaster Universities Osteoarthritis Index and the short-form Medical Outcomes Study Survey in a randomized, clinical trial of osteoarthritis patients. Arthritis Care Res. 1999;12:172-9. [PMID: 10513507]
42. Day R, Morrison B, Luza A, Castaneda O, Strusberg A, Nahir M, et al. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group. Arch Intern Med. 2000; 160:1781-7. [PMID: 10871971]
43. Saag K, van der Heijde D, Fisher C, Samara A, DeTora L, Bolognese J, et al. Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal antiinflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group. Arch Fam Med. 2000;9: 1124-34. [PMID: 11115219]
44. Wiesenhutter CW, Boice JA, Ko A, Sheldon EA, Murphy FT, Wittmer BA, et al; Protocol 071 Study Group. Evaluation of the comparative efficacy of etoricoxib and ibuprofen for treatment of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial. Mayo Clin Proc. 2005;80:470-9. [PMID: 15819283]
45. Puopolo A, Boice JA, Fidelholtz JL, Littlejohn TW, Miranda P, Berrocal A, et al. A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis. Osteoarthritis Cartilage. 2007; 15:1348-56. [PMID: 17631392]
46. Dore R, Ballard I, Constantine G, McDonald P. Efficacy and safety of etodolac and naproxen in patients with osteoarthritis of the knee: a double-blind, placebo-controlled study. Clin Ther. 1995;17:656-66. [PMID: 8565029]
47. Fleischmann RM, Flint K, Constantine G, Kolecki B. A doublemasked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group. Clin Ther. 1997;19:642-55. [PMID: 9377610]
48. Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, et al. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Mayo Clin Proc. 1999;74:1095-105. [PMID: 10560596]
49. Zhao SZ, McMillen JI, Markenson JA, Dedhiya SD, Zhao WW, Osterhaus JT, et al. Evaluation of the functional status aspects j of health-related quality of life of patients with osteoarthritis treated with celecoxib. Pharmacotherapy. 1999;19:1269-78. [PMID: 10555933]
50. Kivitz A, Eisen G, Zhao WW, Bevirt T, Recker DP. Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis. J Fam Pract. 2002;51: 530-7. [PMID: 12100776]
51. Lohmander LS, McKeith D, Svensson O, Malmenäs M, Bolin L, Kalla A, et al; STAR Multinational Study Group. A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis. Ann Rheum Dis. 2005;64:449-56. [PMID: 15345500]
52. Svensson O, Malmenäs M, Fajutrao L, Roos EM, Lohmander LS. Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36. Ann Rheum Dis. 2006;65:781-4. [PMID: 16269428]
53. Schnitzer TJ, Kivitz AJ, Lipetz RS, Sanders N, Hee A. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of osteoarthritis of the knee. Arthritis Rheum. 2005;53:827-37. [PMID: 16342089]
54. Reginster JY, Malmstrom K, Mehta A, Bergman G, Ko AT, Curtis SP, et al. Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis. Ann Rheum Dis. 2007;66:945-51. [PMID: 17142385]
55. Leung AT, Malmstrom K, Gallacher AE, Sarembock B, Poor G, Beaulieu A, et al. Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial. Curr Med Res Opin. 2002;18:49-58. [PMID: 12017209]
56. Schnitzer TJ, Kivitz A, Frayssinet H, Duquesroix B. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study. Osteoarthritis Cartilage. 2010;18:629-39. [PMID: 20202489] doi:10.1016/j.joca.2009.12.013
57. Schnitzer TJ, Hochberg MC, Marrero CE, Duquesroix B, Frayssinet H, Beekman M. Efficacy and safety of naproxcinod in patients with osteoarthritis of the knee: a 53-week prospective randomized multicenter study. Semin Arthritis Rheum. 2011;40:285-97. [PMID: 20828790] doi:10.1016/j.semarthrit.2010.06.002
58. Hochberg MC, Fort JG, Svensson O, Hwang C, Sostek M. Fixeddose combination of enteric-coated naproxen and immediaterelease esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials. Curr Med Res Opin. 2011;27: 1243-53. [PMID: 21524238] doi:10.1185/03007995.2011.580340
59. McKenna F, Borenstein D, Wendt H, Wallemark C, Lefkowith JB, Geis GS. Celecoxib versus diclofenac in the management of osteoarthritis of the knee. Scand J Rheumatol. 2001;30:11-8. [PMID: 11252686]
60. Essex MN, Bhadra P, Sands GH. Efficacy and tolerability of celecoxib versus naproxen in patients with osteoarthritis of the knee: a randomized, double-blind, double-dummy trial. J Int Med Res. 2012; 40:1357-70. [PMID: 22971487]
61. Essex MN, O'Connell M, Bhadra Brown P. Response to nonsteroidal anti-inflammatory drugs in African Americans with osteoarthritis of the knee. J Int Med Res. 2012;40:2251-66. [PMID: 23321182]
62. Essex MN, O'Connell MA, Behar R, Brown PB. Response to nonsteroidal anti-inflammatory agents in Asian patients with osteoarthritis of the knee. Osteoarthritis Cartilage. 2013;21 (Suppl):S252-3.
63. Essex MN, Behar R, O'Connell MA, Brown PB. Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis. Int J Gen Med. 2014;7:227-35. [PMID: 24876792] doi:10.2147/IJGM.S61297
64. Williams GW, Ettlinger RE, Ruderman EM, Hubbard RC, Lonien ME, Yu SS, et al. Treatment of osteoarthritis with a once-daily dosing regimen of celecoxib: a randomized, controlled trial. J Clin Rheumatol. 2000;6:65-74. [PMID: 19078452]
65. McKenna F, Weaver A, Fiechtner JJ, Bello AE, Fort JG. COX-2 specific inhibitors in the management of osteoarthritis of the knee: a placebo-controlled, randomized, double-blind study. J Clin Rheumatol. 2001;7:151-9. [PMID: 17039120]
66. Williams GW, Hubbard RC, Yu SS, Zhao W, Geis GS. Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee. Clin Ther. 2001;23:213-27. [PMID: 11293555]
67. Gibofsky A, Williams GW, McKenna F, Fort JG. Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial. Arthritis Rheum. 2003;48:3102-11. [PMID: 14613272]
68. Tannenbaum H, Berenbaum F, Reginster JY, Zacher J, Robinson J, Poor G, et al. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib. Ann Rheum Dis. 2004;63:1419-26. [PMID: 15020310]
69. Fleischmann R, Sheldon E, Maldonado-Cocco J, Dutta D, Yu S, Sloan VS. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib. Clin Rheumatol. 2006;25:42-53. [PMID: 16132165]
70. Lehmann R, Brzosko M, Kopsa P, Nischik R, Kreisse A, Thurston H, et al. Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib. Curr Med Res Opin. 2005;21:517-26. [PMID: 15899100]
71. Sheldon E, Beaulieu A, Paster Z, Dutta D, Yu S, Sloan VS. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo. Clin Ther. 2005;27:64-77. [PMID: 15763607]
72. Birbara C, Ruoff G, Sheldon E, Valenzuela C, Rodgers A, Petruschke RA, et al. Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies. Curr Med Res Opin. 2006;22:199-210. [PMID: 16393445]
73. Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795-808. [PMID: 16495392]
74. Bingham CO 3rd, Sebba AI, Rubin BR, Ruoff GE, Kremer J, Bird S, et al. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Rheumatology (Oxford). 2007;46:496-507. [PMID: 16936327]
75. Boswell DJ, Ostergaard K, Philipson RS, Hodge RA, Blum D, Brown JC, et al. Evaluation of GW406381 for treatment of osteoarthritis of the knee: two randomized, controlled studies. Medscape J Med. 2008;10:259. [PMID: 19099009]
76. Asmus MJ, Essex MN, Brown PB, Mallen SR. Efficacy and tolerability of celecoxib in patients with osteoarthritis who previously did not respond to or did not tolerate naproxen and ibuprofen: results from 2 identically designed randomized trials. Osteoarthritis Cartilage. 2013;21(Suppl):S253.
77. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med. 1991;325:87-91. [PMID: 2052056]
78. Williams HJ, Ward JR, Egger MJ, Neuner R, Brooks RH, Clegg DO, et al. Comparison of naproxen and acetaminophen in a twoyear study of treatment of osteoarthritis of the knee. Arthritis Rheum. 1993;36:1196-206. [PMID: 8216413]
79. Pincus T, Koch GG, Sokka T, Lefkowith J, Wolfe F, Jordan JM, et al. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum. 2001;44:1587-98. [PMID: 11465710]
80. Doherty M, Hawkey C, Goulder M, Gibb I, Hill N, Aspley S, et al. A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain. Ann Rheum Dis. 2011;70:1534-41. [PMID: 21804100] doi:10.1136/ard.2011.154047
81. Geba GP, Weaver AL, Polis AB, Dixon ME, Schnitzer TJ; Vioxx, Acetaminophen, Celecoxib Trial (VACT) Group. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial. JAMA. 2002;287:64-71. [PMID: 11754710]
82. Schnitzer TJ, Weaver AL, Polis AB, Petruschke RA, Geba GP; VACT-1 and VACT-2 (Protocols 106 and 150) Study Groups. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies. J Rheumatol. 2005;32:1093-105. [PMID: 15940774]
83. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage. 1995;3:213-25. [PMID: 8689457]
84. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol. 1998; 25:2203-12. [PMID: 9818665]
85. Dickson DJ, Hosie G, English JR. A double blind, placebocontrolled comparison of hylan GF-20 against diclofenac in knee OA. J Clin Res. 2001;4:41-52.
86. Petrella RJ, DiSilvestro MD, Hildebrand C. Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med. 2002;162:292-8. [PMID: 11822921]
87. Ishijima M, Nakamura T, Shimizu K, Hayashi K, Kikuchi H, Soen S, et al; Research Group of Cartilage Metabolism. Intra-articular hyaluronic acid injection versus oral non-steroidal anti-inflammatory drug for the treatment of knee osteoarthritis: a multi-center, randomized, open-label, non-inferiority trial. Arthritis Res Ther. 2014;16:R18. [PMID: 24443804] doi:10.1186/ar4446
88. Novartis N. A randomized, double blind, placebo and Naproxen controlled, multi-center, study to determine the safety, tolerability, pharmacokinetics and effect on pain of a single intra-articular administration of Canakinumab in patients with osteoarthritis in the knee. [CACZ885C2201]. Novartis Clinical Trial Results Database. 2012.
89. Leardini G, Franceschini M, Mattara L, Bruno R, Pebrellini A. Intra-articular sodium hyaluronate (Hyalgan) in gonarthrosis: a controlled study comparing methylprednisolone acetate. Clin Trials J. 1987;24:341-50.
90. Leardini G, Mattara L, Franceschini M, Perbellini A. Intra-articular treatment of knee osteoarthritis. A comparative study between hyaluronic acid and 6-methyl prednisolone acetate. Clin Exp Rheumatol. 1991;9:375-81. [PMID: 1934686].
91. Pietrogrande V, Melanotte PL, D'Agnolo B, Ulivi M, Benigni GA, Turchetto L. Hyaluronic acid versus methylprednisolone intraarticularly injected for treatment of osteoarthritis of the knee. Curr Ther Res. 1991;50:691-701.
92. Jones AC, Pattrick M, Doherty S, Doherty M. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis Cartilage. 1995;3: 269-73. [PMID: 8689462]
93. Tekeoglu I, Adak B, Goksoy T, Tosun N. Effects of intra-articular injection of sodium hyaluronate (Orthovisc) and betamethasone on osteoarthritis of the knee. J Rheum Med Rehab. 1998;9(4):220-224.
94. Frizziero L, Pasquali Ronchetti I. Intra-articular treatment of osteoarthritis of the knee: an arthroscopic and clinical comparison between sodium hyaluronate (500-730 kDa) and methylprednisolone acetate. J Orthop Traumatol. 2002;3:89-96.
95. Tasciotaoglu F, Oner C. Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clin Rheumatol. 2003; 22:112-7. [PMID: 12740675]
96. Caborn D, Rush J, Lanzer W, Parenti D, Murray C; Synvisc 901 Study Group. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol. 2004;31:333-43. [PMID: 14760806]
97. Skwara A, Ponelis R, Tibesku CO, Rosenbaum D, Fuchs-Winkelmann S. Gait patterns after intraarticular treatment of patients with osteoarthritis of the knee-hyaluronan versus triamcinolone: a prospective, randomized, doubleblind, monocentric study. Eur J Med Res. 2009;14:157-64. [PMID: 19380288]
98. Skwara A, Peterlein CD, Tibesku CO, Rosenbaum D, Fuchs-Winkelmann S. Changes of gait patterns and muscle activity after intraarticular treatment of patients with osteoarthritis of the knee: a prospective, randomised, doubleblind study. Knee. 2009;16:466-72. [PMID: 19362003] doi:10.1016/j.knee.2009.03.003
99. Shimizu M, Higuchi H, Takagishi K, Shinozaki T, Kobayashi T. Clinical and biochemical characteristics after intra-articular injection for the treatment of osteoarthritis of the knee: prospective randomized study of sodium hyaluronate and corticosteroid. J Orthop Sci. 2010;15:51-6. [PMID: 20151251] doi:10.1007/s00776-009-1421-0
100. Housman L, Arden N, Schnitzer TJ, et al. Intra-articular hylastan versus steroid for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2014;22:1684-92.
101. Leighton R, Akermark C, Therrien R, Richardson JB, Andersson M, Todman MG, et al; DUROLANE Study Group. NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. Osteoarthritis Cartilage. 2014;22:17-25. [PMID: 24185114] doi:10.1016/j.joca.2013.10.009
102. Shichikawa K, Igarashi M, Sugawara S, Iwasaki Y. Clinical evaluation of high molecular weight sodium hyaluronate (SPH) on osteoarthritis of the knee-a multi-center well controlled comparative study. Jpn J Clin Pharmacol Therapeut. 1983;14:545-58.
103. Shichikawa K, Maeda A, Ogawa N. [Clinical evaluation of sodium hyaluronate in the treatment of osteoarthritis of the knee]. Ryumachi. 1983;23:280-90. [PMID: 6364389]
104. Bragantini A, Cassini M, De Bastiani G, Perbellini A. Controlled single-blind trial of intra-articulary injected hyaluronic acid (Hyalgan®) in osteoarthritis of the knee. Clin Trials J. 1987;24:333-40.
105. Grecomoro G, Martorana U, Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica. 1987;5:137-41. [PMID: 3310017]
106. Dixon AS, Jacoby RK, Berry H, Hamilton EB. Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin. 1988;11:205-13. [PMID: 3063436]
107. Russell IJ MJ, Lawrence VA, Lessard JA, Briggs BT, May GS. A randomized placebo (PL) and no-intervention (NI) controlled, trial of intra-articular (IA) 1% sodium hyaluronate (HA) in the treatment of knee osteoarthritis (OA). Arthritis Rheum. 1992;(35 Suppl):S132.
108. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage. 1993;1:97-103. [PMID: 8886085]
109. Moreland LW, Arnold WJ, Saway A, Savory C, Sikes D. Efficacy and safety of intra-articular Hylan G-F20 (Synvisc®), a viscoelastic derivative of hyaluronan, in patients with osteoarthritis of the knee. Arthritis Rheum. 1993;36:S165.
110. Puhl W, Bernau A, Greiling H, Köpcke W, Pförringer W, Steck KJ, et al. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthritis Cartilage. 1993;1:233-41. [PMID: 15449510]
111. Cohen MA, Shiroky JB, Ballachey ML, Neville C, Esdaile JM. Double-blind randomized trial of intra-articular (I/A) hyaluronate in the treatment of osteoarthritis of the knee. Arthritis Rheum. 1994; 37(Suppl):R31.
112. Creamer P, Sharif M, George E, Meadows K, Cushnaghan J, Shinmei M, et al. Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthritis Cartilage. 1994;2:133-40. [PMID: 11548229]
113. Dahlberg L, Lohmander LS, Ryd L. Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain. A one-year double-blind, placebo-controlled study. Arthritis Rheum. 1994;37:521-8. [PMID: 8147929]
114. Henderson EB, Smith EC, Pegley F, Blake DR. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis. 1994;53: 529-34. [PMID: 7944639]
115. Scale D, Wobig M, Wolpert W. Viscosupplementation of osteoarthritic knees with hylan: A treatment schedule study. Curr Therap Res Clin Exp. 1994;55:220-32.
116. Carrabba M, Paresce E, Angelini M, Re KA, Torchiana EEM, Perbellini A. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm. 1995;15:25-31.
117. Corrado EM, Peluso GF, Gigliotti S, et al. The effects of intraarticular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. Eur J Rheumatol Inflamm. 1995;15:47-56.
118. Sodium Hyaluronate (SUPARTZ) PMA P980044: Summary of Safety and Effectiveness Data. 24 January 2001. Accessed at www .accessdata.fda.gov/cdrh-docs/pdf/P980044b.pdf on 20 September 2013.
119. Formiguera Sala S, Esteve de Miguel R. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a short term study. Eur J Rheumatol Inflamm. 1995;15:33-8.
120. Lohmander LS, Dalén N, Englund G, Hämäläinen M, Jensen EM, Karlsson K, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis. 1996;55:424-31. [PMID: 8774159]
121. Wu JJ, Shih LY, Hsu HC, Chen TH. The double-blind test of sodium hyaluronate (ARTZ) on osteoarthritis knee. Zhonghua Yi Xue Za Zhi (Taipei). 1997;59:99-106. [PMID: 9175299]
122. Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther. 1998;20:410-23. [PMID: 9663358]
123. Huskisson EC, Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford). 1999;38:602-7. [PMID: 10461471]
124. Brandt KD, Block JA, Michalski JP, Moreland LW, Caldwell JR, Lavin PT. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop Relat Res. 2001:130-43. [PMID: 11302304]
125. Bunyaratavej N, Chan KM, Subramanian N. Treatment of painful osteoarthritis of the knee with hyaluronic acid. Results of a multicenter Asian study. J Med Assoc Thai. 2001;84 Suppl 2:S576-81. [PMID: 11853284]
126. Tamir E, Robinson D, Koren R, Agar G, Halperin N. Intraarticular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol. 2001;19:265-70. [PMID: 11407078]
127. Karlsson J, Sjögren LS, Lohmander LS. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology (Oxford). 2002;41:1240-8. [PMID: 12421996]
128. Saravanan VMT, Stobbs D, Daymond TJ. Inflammatory effusion after viscosupplementation with Hylan G-F 20 [Abstract 336]. Rheumatology. 2002;41(Suppl 1):121.
129. Jubb RW, Piva S, Beinat L, Dacre J, Gishen P. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract. 2003;57:467-74. [PMID: 12918884]
130. Tsai CL, Chang CC, Chen SC, Beinat L, Piva S. Treatment of knee osteoarthritis in Asian population with an intra-articular hyaluronan of MW 500-730 KDa [Abstract P333]. Osteoarthritis Cartilage. 2003;11(Suppl A):119.
131. Altman RD, Akermark C, Beaulieu AD, Schnitzer T; Durolane International Study Group. Efficacy and safety of a single intraarticular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage. 2004;12:642-9. [PMID: 15262244]
132. Day R, Brooks P, Conaghan PG, Petersen M; Multicenter Trial Group. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol. 2004;31:775-82. [PMID: 15088306]
133. Pham T, Le Henanff A, Ravaud P, Dieppe P, Paolozzi L, Dougados M. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis. 2004;63:1611-7. [PMID: 15331394]
134. Cubukçu D, Ardiç F, Karabulut N, Topuz O. Hylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol. 2005;24:336-41. [PMID: 15599642]
135. Neustadt D, Caldwell J, Bell M, Wade J, Gimbel J. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial. J Rheumatol. 2005;32:1928-36. [PMID: 16206349]
136. Rolf CG, Engstrom B, Ohrvik J, Valentin A, Lilja B, Levine DW. A comparative study of the efficacy and safety of hyaluronan viscosupplements and placebo in patients with symptomatic and arthroscopy-verified cartilage pathology. J Drug Assess. 2005;8:183-200.
137. Sezgin M, Demirel AC, Karaca C, Ortancil O, Ulkar GB, Kanik A, et al. Does hyaluronan affect inflammatory cytokines in knee osteoarthritis? Rheumatol Int. 2005;25:264-9. [PMID: 14999424]
138. Kotevoglu N, Iyibozkurt PC, Hiz O, Toktas H, Kuran B. A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int. 2006;26:325-30. [PMID: 15959784]
139. Petrella RJ, Petrella M. A prospective, randomized, doubleblind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol. 2006; 33:951-6. [PMID: 16652426]
140. Blanco FJ, Fernández-Sueiro JL, Pinto-Tasende JA, et al. Intraarticular hyaluronan treatment of patients with knee osteoarthritis waiting for replacement surgery. Open Arthritis J. 2008;1:1-7.
141. Lundsgaard C, Dufour N, Fallentin E, Winkel P, Gluud C. Intraarticular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial. Scand J Rheumatol. 2008;37:142-50. [PMID: 18415773] doi:10.1080/03009740701813103
142. Petrella RJ, Cogliano A, Decaria J. Combining two hyaluronic acids in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Clin Rheumatol. 2008;27:975-81. [PMID: 18204873] doi:10.1007/s10067-007-0834-4
143. Sanofi-Aventis. A double blind, randomized trial of intraarticular injections of 20 mg of HYALGAN for the treatment of knee pain due to osteoarthritis [NCT00130468]. 2008. Accessed at http: //en.sanofi.com/img/content/study/L-9385-summary.pdf on 8 July 2015.
144. Altman RD, Rosen JE, Bloch DA, Hatoum HT, Korner P. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial). Semin Arthritis Rheum. 2009;39:1-9. [PMID: 19539353] doi:10.1016/j.semarthrit.2009.04.001
145. Baltzer AW, Moser C, Jansen SA, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage. 2009;17:152-60. [PMID: 18674932] doi:10.1016/j.joca.2008.06.014
146. Diracoglu D, Vural M, Baskent A, Dikici F, Aksoy C. The effect of viscosupplementation on neuromuscular control of the knee in patients with osteoarthritis. J Back Musculoskelet Rehabil. 2009;22:1-9. [PMID: 20023357] doi:10.3233/BMR-2009-0207
147. Chevalier X, Jerosch J, Goupille P, van Dijk N, Luyten FP, Scott DL, et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis. 2010;69:113-9. [PMID: 19304567] doi:10.1136/ard.2008.094623
148. Jørgensen A, Stengaard-Pedersen K, Simonsen O, Pfeiffer-Jensen M, Eriksen C, Bliddal H, et al. Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis. 2010;69:1097-102. [PMID: 20447955] doi:10.1136/ard.2009.118042
149. Kul-Panza E, Berker N. Is hyaluronate sodium effective in the management of knee osteoarthritis? A placebo-controlled doubleblind study. Minerva Med. 2010;101:63-72. [PMID: 20467406]
150. Huang TL, Chang CC, Lee CH, Chen SC, Lai CH, Tsai CL. Intraarticular injections of sodium hyaluronate (Hyalgan®) in osteoarthritis of the knee. a randomized, controlled, double-blind, multicenter trial in the Asian population. BMC Musculoskelet Disord. 2011;12:221. [PMID: 21978211] doi:10.1186/1471-2474-12-221
151. Navarro-Sarabia F, Coronel P, Collantes E, Navarro FJ, de la Serna AR, Naranjo A, et al; AMELIA study group. A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project. Ann Rheum Dis. 2011;70:1957-62. [PMID: 21852252] doi:10.1136/ard.2011.152017
152. DeCaria JE, Montero-Odasso M, Wolfe D, Chesworth BM, Petrella RJ. The effect of intra-articular hyaluronic acid treatment on gait velocity in older knee osteoarthritis patients: a randomized, controlled study. Arch Gerontol Geriatr. 2012;55:310-5. [PMID: 22169699] doi:10.1016/j.archger.2011.11.007
153. Ferring Pharmaceuticals. A 26 week, double-blind, randomized, placebo-controlled study of the efficacy and safety of single intra-articular injection 1.2% sodium hyaluronate for treatment of painful osteoarthritis of the knee, with optional 26-week open-label safety extension (NCT00988091) Last updated 13 June 2012 Accessed at https://clinicaltrials.gov/ct2/show/NCT00988091?term=NCT00988091&rank=1 on 12 May 2015.
154. Kosuwon W, Sirichatiwapee W, Visanuyotin T, Jeeravipoolvarn P, Laupattarakasem W. Determination of cartilage volume using MRI in patients with knee osteoarthritis: efficacy study of 25 milligrams of sodium hyaluronate (2.5 Ml) versus placebo. Clin Exp Pharmacol. 2012;2(2).
155. Strand V, Baraf HS, Lavin PT, Lim S, Hosokawa H. A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid, to phosphate buffered saline for treatment of osteoarthritis of the knee. Osteoarthritis Cartilage. 2012;20:350-6. [PMID: 22342928] doi:10.1016/j.joca.2012.01.013
156. Arden NK, Åkermark C, Andersson M, Todman MG, Altman RD. A randomized saline-controlled trial of NASHA hyaluronic acid for knee osteoarthritis. Curr Med Res Opin. 2014;30:279-86. [PMID: 24168077] doi:10.1185/03007995.2013.855631
157. van der Weegen W, Wullems JA, Bos E, Noten H, van Drumpt RA. No difference between intra-articular injection of hyaluronic Acid and placebo for mild to moderate knee osteoarthritis: a randomized, controlled, double-blind trial. J Arthroplasty. 2015;30:754-7. [PMID: 25548079] doi:10.1016/j.arth.2014.12.012
158. Friedman DM, Moore ME. The efficacy of intraarticular steroids in osteoarthritis: a double-blind study. J Rheumatol. 1980;7:850-6. [PMID: 7009857]
159. Gaffney K, Ledingham J, Perry JD. Intra-articular triamcinolone hexacetonide in knee osteoarthritis: factors influencing the clinical response. Ann Rheum Dis. 1995;54:379-81. [PMID: 7794044]
160. Jones A, Doherty M. Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. Ann Rheum Dis. 1996;55:829-32. [PMID: 8976640]
161. Ravaud P, Moulinier L, Giraudeau B, Ayral X, Guerin C, Noel E, et al. Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial. Arthritis Rheum. 1999;42:475-82. [PMID: 10088770]
162. Raynauld JP, Buckland-Wright C, Ward R, Choquette D, Haraoui B, Martel-Pelletier J, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2003;48:370-7. [PMID: 12571845]
163. Chao J, Wu C, Sun B, Hose MK, Quan A, Hughes TH, et al. Inflammatory characteristics on ultrasound predict poorer long-term response to intraarticular corticosteroid injections in knee osteoarthritis. J Rheumatol. 2010;37:650-5. [PMID: 20080918] doi:10.3899/jrheum.090575
164. Yavuz U, Sökücü S, Albayrak A, Oztürk K. Efficacy comparisons of the intraarticular steroidal agents in the patients with knee osteoarthritis. Rheumatol Int. 2012;32:3391-6. [PMID: 22057944] doi:10.1007/s00296-011-2188-0
165. Ottillinger B, Gömör B, Michel BA, Pavelka K, Beck W, Elsasser U. Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis. Osteoarthritis Cartilage. 2001;9:273-80. [PMID: 11300751]
166. Bookman AA, Williams KS, Shainhouse JZ. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ. 2004;171:333-8. [PMID: 15313991]
167. Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med. 2004;164:2017-23. [PMID: 15477437]
168. Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol. 2004;31:2002-12. [PMID: 15468367]
169. Baer PA, Thomas LM, Shainhouse Z. Treatment of osteoarthritis of the knee with a topical diclofenac solution: a randomised controlled, 6-week trial [ISRCTN53366886]. BMC Musculoskelet Disord. 2005;6:44. [PMID: 16086839]
170. Baraf HS, Gloth FM, Barthel HR, Gold MS, Altman RD. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials. Drugs Aging. 2011;28:27-40. [PMID: 21174485] doi:10.2165/ 11584880-000000000-00000
171. Baraf HS, Gold MS, Clark MB, Altman RD. Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial. Phys Sportsmed. 2010;38:19-28. [PMID: 20631460] doi:10.3810/psm.2010.06.1779
172. Barthel HR, Haselwood D, Longley S 3rd, Gold MS, Altman RD. Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum. 2009;39:203-12. [PMID: 19932833] doi:10.1016/j.semarthrit.2009.09.002
173. Conaghan PG, Dickson J, Bolten W, Cevc G, Rother M. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology (Oxford). 2013;52:1303-12. [PMID: 23542612] doi:10.1093/rheumatology/ket133
174. Kneer W, Rother M, Mazgareanu S, Seidel EJ; European IDEA- 033 study group. A 12-week randomized study of topical therapy with three dosages of ketoprofen in Transfersome gel (IDEA-033) compared with the ketoprofen-free vehicle (TDT 064), in patients with osteoarthritis of the knee. J Pain Res. 2013;6:743-53. [PMID: 24187510] doi:10.2147/JPR.S51054
175. Rother M, Conaghan PG. A randomized, double-blind, phase III trial in moderate osteoarthritis knee pain comparing topical ketoprofen gel with ketoprofen-free gel. J Rheumatol. 2013;40:1742-8. [PMID: 23996292] doi:10.3899/jrheum.130192
176. Sandelin J, Harilainen A, Crone H, Hamberg P, Forsskåhl B, Tamelander G. Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee. A double blind study comparing eltenac with oral diclofenac and placebo gel. Scand J Rheumatol. 1997;26:287-92. [PMID: 9310109]
177. Rother M, Lavins BJ, Kneer W, Lehnhardt K, Seidel EJ, Mazgareanu S. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. Ann Rheum Dis. 2007;66:1178-83. [PMID: 17363401]
178. Simon LS, Grierson LM, Naseer Z, Bookman AA, Zev Shainhouse J. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain. 2009;143: 238-45. [PMID: 19380203] doi:10.1016/j.pain.2009.03.008